| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 123,288 | 114,426 | 144,493 | 199,737 | | Cost of Revenue | 8,789 | (404,920) | 376,890 | 13,297 | | | Gross Profit | 114,499 | 519,346 | (232,397) | 186,440 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 118,439 | 521,586 | (240,908) | 162,071 | | Non Recurring | 18,183 | 25,070 | 16,845 |
-
| | Others | 2,829 | 2,946 | 2,924 | 2,881 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (24,952) | (30,256) | (11,258) | 21,488 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,733 | 2,903 | (14,794) | (104) | | Earnings Before Interest And Taxes | (20,219) | (27,353) | (26,052) | 21,384 | | Interest Expense | 1,442 | 1,839 | 1,267 | 1,080 | | Income Before Tax | (21,661) | (29,192) | (27,319) | 20,304 | | Income Tax Expense | (7,365) | (11,943) | (4,549) | 7,583 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,273) | (17,200) | (22,356) | 13,560 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,273) | (17,200) | (22,356) | 13,560 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,273) | ($17,200) | ($22,356) | $13,560 |
|
0.01% Nasdaq 0.00%
Income Statement
